Logo image of CNVI.CA

CONAVI MEDICAL CORP (CNVI.CA) Stock Fundamental Analysis

Canada - TSX-V:CNVI - CA2059531020 - Common Stock

0.61 CAD
-0.01 (-1.61%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CNVI. CNVI was compared to 15 industry peers in the Health Care Equipment & Supplies industry. CNVI may be in some trouble as it scores bad on both profitability and health. CNVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNVI had negative earnings in the past year.
CNVI had a negative operating cash flow in the past year.
In the past 5 years CNVI reported 4 times negative net income.
In the past 5 years CNVI reported 4 times negative operating cash flow.
CNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -140.24%, CNVI perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
ROA -140.24%
ROE N/A
ROIC N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVI.CA Yearly ROA, ROE, ROICCNVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5K 10K

1.3 Margins

CNVI's Operating Margin has improved in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for CNVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNVI.CA Yearly Profit, Operating, Gross MarginsCNVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

CNVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNVI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNVI has more shares outstanding
CNVI has a better debt/assets ratio than last year.
CNVI.CA Yearly Shares OutstandingCNVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CNVI.CA Yearly Total Debt VS Total AssetsCNVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -21.05, we must say that CNVI is in the distress zone and has some risk of bankruptcy.
CNVI's Altman-Z score of -21.05 is in line compared to the rest of the industry. CNVI outperforms 46.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.05
ROIC/WACCN/A
WACC7.68%
CNVI.CA Yearly LT Debt VS Equity VS FCFCNVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M

2.3 Liquidity

CNVI has a Current Ratio of 0.59. This is a bad value and indicates that CNVI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, CNVI is in line with its industry, outperforming 53.33% of the companies in the same industry.
A Quick Ratio of 0.58 indicates that CNVI may have some problems paying its short term obligations.
With a Quick ratio value of 0.58, CNVI perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.58
CNVI.CA Yearly Current Assets VS Current LiabilitesCNVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CNVI have decreased strongly by -128.21% in the last year.
Looking at the last year, CNVI shows a very strong growth in Revenue. The Revenue has grown by 821.58%.
Measured over the past years, CNVI shows a small growth in Revenue. The Revenue has been growing by 6.62% on average per year.
EPS 1Y (TTM)-128.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.51%
Revenue 1Y (TTM)821.58%
Revenue growth 3Y6.62%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CNVI will show a very negative growth in Earnings Per Share. The EPS will decrease by -30.51% on average per year.
The Revenue is expected to grow by 1.86% on average over the next years.
EPS Next YN/A
EPS Next 2Y-163.42%
EPS Next 3Y-64.72%
EPS Next 5Y-30.51%
Revenue Next YearN/A
Revenue Next 2Y-39.82%
Revenue Next 3Y-38.05%
Revenue Next 5Y1.86%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNVI.CA Yearly Revenue VS EstimatesCNVI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2025 2026 2027 2028 2029 20M 40M 60M
CNVI.CA Yearly EPS VS EstimatesCNVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2025 2026 2027 2028 2029 -1 -2 -3 -4 -5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNVI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVI.CA Price Earnings VS Forward Price EarningsCNVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNVI.CA Per share dataCNVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

CNVI's earnings are expected to decrease with -64.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-163.42%
EPS Next 3Y-64.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNVI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONAVI MEDICAL CORP

TSX-V:CNVI (11/7/2025, 7:00:00 PM)

0.61

-0.01 (-1.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-10 2025-11-10
Inst Owners0.33%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap46.82M
Revenue(TTM)8.76M
Net Income(TTM)-16.22M
Analysts80
Price Target1.02 (67.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.11
BVpS-0.31
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -140.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-183.23%
ROA(5y)-374.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y34.2%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.35%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.58
Altman-Z -21.05
F-Score2
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)113.75%
Cap/Depr(5y)424.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-128.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.51%
EPS Next YN/A
EPS Next 2Y-163.42%
EPS Next 3Y-64.72%
EPS Next 5Y-30.51%
Revenue 1Y (TTM)821.58%
Revenue growth 3Y6.62%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2Y-39.82%
Revenue Next 3Y-38.05%
Revenue Next 5Y1.86%
EBIT growth 1Y-348.02%
EBIT growth 3Y43.09%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.41%
OCF growth 3YN/A
OCF growth 5YN/A

CONAVI MEDICAL CORP / CNVI.CA FAQ

What is the fundamental rating for CNVI stock?

ChartMill assigns a fundamental rating of 1 / 10 to CNVI.CA.


What is the valuation status for CNVI stock?

ChartMill assigns a valuation rating of 0 / 10 to CONAVI MEDICAL CORP (CNVI.CA). This can be considered as Overvalued.


How profitable is CONAVI MEDICAL CORP (CNVI.CA) stock?

CONAVI MEDICAL CORP (CNVI.CA) has a profitability rating of 1 / 10.